This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wind River Drives 15% Reduction In Development Cycle Time And Costs For Olympus Surgical

Wind River ® , a world leader in embedded and mobile software, has announced that Olympus Surgical, the technology leader in the field of minimally invasive surgery, chose Wind River Platform for Medical Devices and Wind River Test Management to help reduce development cycle time and costs for its latest high-frequency surgical generator, the ESG-400.

In addition to wanting to be first to market with the ESG-400, Olympus needed to aggressively manage costs to stay on budget; IEC 62304 certification and U.S. Food and Drug Administration (FDA) approval were also required to validate the product’s safety. To meet these objectives, Olympus selected Wind River Platform for Medical Devices, part of a comprehensive software portfolio that is built on the Wind River real-time operating system, VxWorks ®, as well as Wind River Test Management, the company’s automated software testing framework.

By leveraging Wind River Platform for Medical Devices, Olympus reduced the overall development cycle time by 15% and entered the market much sooner, while lowering costs by approximately 15%. With Wind River Test Management, Olympus was able to accelerate time-to-quality (the time it takes to successfully execute all tests that cover the requirements) by 20% and reduce the time to regulatory submission by 20%.

“Wind River delivered a total solution that included not just software, but also strong customer support, education, and professional services organizations to ensure the successful market launch of an FDA-approved product,” said Lutz Kersten, department manager, R&D surgical therapy software, Olympus Surgical. “Wind River’s software helped us develop customized documentation in accordance with IEC 62304 and FDA guidance. We passed the software audit easily and quickly—and launched the FDA-approved product to the market ahead of schedule.”

“Wind River has enabled Olympus to continue its heritage of meeting first-to-market goals and delivering a high-quality product to the medical market,” said Santhosh Nair, general manager of intelligent platforms at Wind River. “We provided Olympus with a complete solution and services customized to best meet their needs, allowing them to stay focused on their core competencies—developing cutting-edge, differentiated applications.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs